Finasteride has been FDA-approved for male pattern hair loss since 1997 with a 25-year safety record. Here’s what it actually does in the body, what the clinical data shows, and what to realistically expect.
By Dr. Teja V. Surapaneni, MD, MS • Board-Certified Internal Medicine (ABIM) • Licensed NV, WA, OR, WI • May 2026
Male pattern hair loss (androgenetic alopecia) is driven primarily by dihydrotestosterone (DHT) — a potent androgen derived from testosterone through the action of an enzyme called 5-alpha reductase. DHT binds to androgen receptors in genetically susceptible hair follicles, progressively shrinking them over time. This process, called follicular miniaturization, gradually turns thick terminal hairs into thin vellus hairs, and eventually causes follicular dormancy.
The rate and pattern of loss is largely genetic and inherited from both sides of the family — not just the maternal line as is commonly believed. But DHT is the biochemical trigger, and blocking DHT is the mechanism finasteride exploits.
Finasteride is a 5-alpha reductase inhibitor. It blocks the enzyme responsible for converting testosterone into DHT, reducing scalp DHT levels by approximately 60–70%. With less DHT available, the follicular miniaturization process slows dramatically — and in many patients partially reverses.
Importantly, finasteride doesn’t regrow hair from scratch. It works by preserving follicles that are still active and allowing partially miniaturized follicles to recover. Starting earlier in the hair loss process produces better results than starting after significant follicle loss has already occurred.
In the pivotal Phase 3 trials for finasteride 1 mg in male pattern hair loss:
The medication must be taken consistently. Discontinuing finasteride results in DHT levels returning to baseline within weeks, and the hair loss process resumes — often with accelerated shedding in the months following discontinuation.
Finasteride 1 mg is FDA-approved for men with androgenetic alopecia. It is contraindicated in anyone who is pregnant or may become pregnant due to risk of fetal harm, and they should not handle crushed or broken tablets. It is most effective for men with hair loss at the crown and mid-scalp — limited effectiveness on a fully receded hairline where follicles are dormant.
The ideal candidate is a man in his 20s through 50s with active, progressive hair loss who still has functioning follicles in the affected areas.
The most discussed side effects of finasteride are sexual — reduced libido, erectile dysfunction, and reduced ejaculate volume — and occur in approximately 2–4% of men in clinical trials (compared to roughly 1% on placebo). These effects are usually reversible after stopping, although rare persistent effects have been reported.
Rare reports describe sexual, mood, or other effects that persist after stopping (sometimes called post-finasteride syndrome). How often this happens and why are not well established, but the reports are taken seriously and the FDA label reflects them. Our physicians discuss this openly during consultation. Also tell any physician checking your PSA that you take finasteride, because it lowers PSA by about 50%.
For most men, finasteride is a low-burden, once-daily oral medication with a long safety record.
For men with moderate to significant hair loss, combination therapy — finasteride (addressing the androgen pathway) plus minoxidil (a topical vasodilator that stimulates follicle activity via a separate mechanism) — produces better outcomes than either medication alone. At YourMD there are no bundles: the oral finasteride 1 mg plan is $29/month and includes minoxidil 5% if your physician recommends it, and a compounded topical finasteride + minoxidil (± tretinoin) is $35/month.
Our hair restoration program starts with a physician consultation with a board-certified MD. Oral finasteride 1 mg daily (with minoxidil 5% if recommended) is $29/month; minoxidil 5% alone is $29/month. A compounded topical finasteride + minoxidil (± tretinoin) is $35/month — a compounded preparation, not FDA-approved (there is no FDA-approved topical finasteride in the US), prepared by a licensed 503A compounding pharmacy (for example Hallandale Pharmacy or Valiant Compounding Pharmacy) named on your prescription label. Low-dose oral minoxidil may be considered by your physician at your consult (off-label); it is not a self-serve plan. Your physician will recommend the right approach based on your degree of hair loss, timeline, and health history.

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Consult a qualified physician before starting any prescription medication. Page medically reviewed by Teja V. Surapaneni, MD, MS — Board-Certified Internal Medicine (NV, WA, OR, WI). Last reviewed: May 2026.